Inventors list

Agents list

Assignees list

List by place

Classification tree browser

Top 100 Inventors

Top 100 Agents

Top 100 Assignees

DAVID S. RESNICK

BOSTON, MA US

1. 20110046686 3-DIMENSIONAL SILK HYDROXYAPATITE COMPOSITIONS 02-24-2011
2. 20110045002 METHODS OF MODULATING IMMUNE RESPONSES BY MODULATING TIM-1, TIM-2 AND TIM-4 FUNCTION 02-24-2011
3. 20110044999 IL-32 MODULATORS - methods of screening for modulators of interleukin 32 , to modulators of IL-32 and to their use 02-24-2011
4. 20110035817 SIVA 3, ITS PREPARATION AND USE - splice variant of SIVA, SIVA3, and to its use 02-10-2011
5. 20110033837 IMMORTALIZED HUMAN CD4-POSITIVE CELL AND ITS USE FOR DETERMINING THE PHENOTYPE OF A HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 02-10-2011
6. 20110033430 METHODS FOR THE INDUCTION OF A CELL TO ENTER THE ISLET 1+ LINEAGE AND A METHOD FOR THE EXPANSION THEREOF 02-10-2011
7. 20110028561 PROTECTION OF NEURAL RETINA BY REDUCTION OF ROD METABOLISM 02-03-2011
8. 20110027338 BIOLOGIC REPLACEMENT FOR FIBRIN CLOT - The invention provides composition and methods for repairing a ruptured anterior cruciate ligament 02-03-2011
9. 20110027186 TAZ/WWTR1 FOR DIAGNOSIS AND TREATMENT OF CANCER 02-03-2011
10. 20110021451 LIPID TUMOUR PROFILE - We describe a method of generating a classification model capable of distinguishing between two biological states 01-27-2011
11. 20110020326 METHOD OF TREATING POLYCYSTIC KIDNEY DISEASE 01-27-2011
12. 20110014303 METHOD FOR THE TREATMENT OF CANCER - surprising finding that treatment with a chemotherapeutic agent such as 5-fluorouracil and an autophagy inducer 01-20-2011
13. 20110014164 EFFICIENT INDUCTION OF PLURIPOTENT STEM CELLS USING SMALL MOLECULE COMPOUNDS 01-20-2011
14. 20110009370 METHOD TO ENHANCE TISSUE REGENERATION - for compositions and methods for modulating tissue growth using tissue growth modulators 01-13-2011
15. 20110004952 METHOD FOR THE SEPARATION OF CELLS - cell containing a gene encoding a conditional transgenic surface marker that is detectable upon expression on the 01-06-2011
16. 20110003704 USE OF MICROVESICLES IN DIAGNOSIS AND PROGNOSIS OF MEDICAL DISEASES AND CONDITIONS 01-06-2011
17. 20110003327 METHODS FOR PRODUCTION OF ATRIAL PROGENITORS AND THEIR DIFFERENTIATION INTO SMOOTH MUSCLE CELLS AND CARDIOMYOCYTES 01-06-2011
18. 20110003008 MESENCHYMAL STEM CELL PARTICLES - We describe a particle secreted by a mesenchymal stem cell and comprising at least one biological property of a 01-06-2011
19. 20110002919 ANTAGONISTS OF NEUROPILIN RECEPTOR FUNCTION AND USE THEREOF 01-06-2011
20. 20100331240 METHODS FOR PREVENTION AND TREATMENT OF INFECTIONS WITH SUPRAPHYSIOLOGICAL DOSES OF MANNAN-BINDING LECTIN (MBL) AND FICOLIN-MBL FUSION PROTEINS 12-30-2010
21. 20100330629 ROBUST MULTI-ENZYME PREPARATION FOR THE SYNTHESIS OF FATTY ACID ALKYL ESTERS 12-30-2010
22. 20100323371 STROMAL INTERACTING MOLECULE KNOCKOUT MOUSE AND USES THEREOF 12-23-2010
23. 20100323027 MESENCHYMAL STEM CELL CONDITIONED MEDIUM 12-23-2010
24. 20100317176 METHOD AND SYSTEM FOR THE SYNTHESIS OF SEMICONDUCTOR NANOWIRES 12-16-2010
25. 20100316628 AGENTS AND METHODS FOR TREATING RESPIRATORY DISORDERS 12-16-2010
26. 20100310583 LET-7 MICRORNA AND MIMETICS THEREOF AS THERAPEUTICS FOR CANCER 12-09-2010
27. 20100304489 METHODS AND COMPOSITIONS FOR HOMOLOGOUS RECOMBINATION IN HUMAN CELLS 12-02-2010
28. 20100304410 METHOD OF ASSESSING COLORECTAL CANCER STATUS IN AN INDIVIDUAL 12-02-2010
29. 20100304369 METHOD AND APPARATUS FOR DIAGNOSING AGE-RELATED MACULAR DEGENERATION 12-02-2010
30. 20100297264 BOWEL PURGATIVE AND USES THEREOF - dry composition for admixture with water for oral administration to a mammal and methods of using the composition for 11-25-2010
31. 20100291185 THERITOL PHOSPHATES, SALTS THEREOF AND METHODS OF USE 11-18-2010
32. 20100291028 USE OF IL-18 INHIBITORS FOR TREATMENT AND/OR PREVENTION OF PERIPHERAL VASCULAR DISEASES 11-18-2010
33. 20100286239 ANTISENSE OLIGONUCLEOTIDES FOR TREATING ATOPIC DISEASES AND NEOPLASTIC CELL PROLIFERATION 11-11-2010
34. 20100285002 TREATMENT OR PREVENTION OF INFLAMMATION BY TARGETING CYCLIN D1 11-11-2010
35. 20100279112 SILK FIBROIN MATERIALS AND USE THEREOF - processes for producing porous silk fibroin scaffold material 11-04-2010
36. 20100278792 METHOD OF ENHANCING PROLIFERATION AND/OR HEMATOPOIETIC DIFFERENTIATION OF STEM CELLS 11-04-2010
37. 20100273859 TREATMENT AND PREVENTION OF HIV INFECTION 10-28-2010
38. 20100273676 HIGH THROUGHPUT SCREENS FOR SMALL-MOLECULE INHIBITORS OF THE NUCLEAR RECEPTOR-LIKE PATHWAY REGULATING MULTIDRUG RESISTANCE IN FUNGI 10-28-2010
39. 20100273160 METHODS TO IDENTIFY AND ENRICH FOR POPULATIONS OF OVARIAN CANCER STEM CELLS AND SOMATIC OVARIAN STEM CELLS AND USES THEREOF 10-28-2010
40. 20100272711 COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES 10-28-2010
41. 20100267140 SOLUBLE INHIBITORS OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND USE THEREOF 10-21-2010
42. 20100267132 IN VITRO PRESERVATION OF LIVING ANIMAL CELLS AND COMPOUNDS SUITABLE FOR USE IN THE PRESERVATION OF LIVING ANIMAL CELLS 10-21-2010
43. 20100267052 COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF TYPE 2 DIABETES 10-21-2010
44. 20100266618 COMPOSITIONS AND METHODS FOR AUGMENTING ACTIVITY OF ONCOLYTIC VIRUSES 10-21-2010
45. 20100256235 DIETARY FORMULATIONS AND METHODS FOR TREATMENT OF INFLAMMATION AND OTHER DISORDERS 10-07-2010
46. 20100255069 COMPOSITIONS AND METHODS FOR TREATING ANGIOGENESIS-RELATED DISEASES, WOUNDS AND COSMETIC USE OF COMPONENTS OF ANGELICA SINENSIS, AND METHODS OF PREPARATION THEREOF 10-07-2010
47. 20100254984 FUSION CONSTRUCTS CONTAINING ACTIVE SECTIONS OF TNF LIGANDS 10-07-2010
48. 20100249025 PEPTIDE ANTAGONISTS OF VASCULAR ENDOTHELIAL GROWTH FACTOR 09-30-2010
49. 20100239578 MODULATION OF SIRP-ALPHA - CD47 INTERACTION FOR INCREASING HUMAN HEMATOPOIETIC STEM CELL ENGRAFTMENT AND COMPOUNDS THEREFOR 09-23-2010
50. 20100233689 PYRAZOLOANTHRONE AND DERIVATIVES THEREOF FOR THE TREATMENT OF CANCER EXPRESSING 'MULLERIAN INHIBITING SUBSTANCE' TYPE II RECEPTOR (MISRII) AND OF EXCESS ANDROGEN STATES 09-16-2010
51. 20100233084 Method for Delivery Across the Blood Brain Barrier 09-16-2010
52. 20100222411 VHZ FOR DIAGNOSIS AND TREATMENT OF CANCER 09-02-2010
53. 20100222371 PREVENTION OF SURGICAL ADHESIONS - methods for treatment of formation or reformation of adhesions particularly in the peritoneal or pelvic cavities 09-02-2010
54. 20100222230 DIAGNOSTIC AND PROGNOSTIC METHODS FOR RENAL CELL CARCINOMA 09-02-2010
55. 20100221266 METHODS TO REGULATE MIRNA PROCESSING BY TARGETING LIN-28 09-02-2010
56. 20100216215 METHOD AND DEVICE FOR THE CONCENTRATION OF MULTIPLE MICROORGANISMS AND TOXINS FROM LARGE LIQUID TOXINS 08-26-2010
57. 20100210713 REGENERATION AND SURVIVAL OF CARDIAC PROGENITORS AND CARDIOMYOCYTES WITH A STRETCH ACTIVATED TRANSCRIPTION FACTOR 08-19-2010
58. 20100209982 MODIFIED-IMMOBILIZED ENZYMES OF HIGH TOLERANCE TO HYDROPHILIC SUBSTRATES IN ORGANIC MEDIA 08-19-2010
59. 20100209440 Targeted Delivery of siRNA - method of delivering RNA interference molecules to a cell or a cell in a subject 08-19-2010
60. 20100209424 ANTIBODIES AND FC FUSION PROTEIN MODIFICATIONS WITH ENHANCED PERSISTENCE OR PHARMACOKINETIC STABILITY IN VIVO AND METHODS OF USE THEREOF 08-19-2010
61. 20100209396 Method of Enhancing Proliferation and/or Hematopoietic Differentiation of Stem Cells 08-19-2010
62. 20100204091 SIVA Ubiquitination and/or Degradation-Related Activity and Modulators Thereof 08-12-2010
63. 20100203226 METHOD FOR FORMING INORGANIC COATINGS - method for forming an inorganic coating on a protein template 08-12-2010
64. 20100203143 SYSTEMS AND METHODS FOR NANOMAGNETIC ACTUATION OF MOLECULAR CELL SIGNALING 08-12-2010
65. 20100197596 Compositions and methods for diagnosis and treatment of type 2 diabetes 08-05-2010
66. 20100197006 MOLECULAR CIRCUITS - Disclosed herein are autonomous molecular circuits that can function in cells 08-05-2010
67. 20100196447 SILK BIOMATERIALS AND METHODS OF USE THEREOF 08-05-2010
68. 20100196426 USE OF MICROVESICLES IN DIAGNOSIS AND PROGNOSIS OF MEDICAL DISEASES AND CONDITIONS 08-05-2010
69. 20100191328 TISSUE-ENGINEERED SILK ORGANS - This invention relates to a lamellae tissue layer, comprising a grooved silk fibroin substrate comprising 07-29-2010
70. 20100190841 GENETIC SUPPRESSION AND REPLACEMENT - gene suppression and replacement 07-29-2010
71. 20100190840 TISSUE SPECIFIC GENE THERAPY TREATMENT - The invention provides nucleic acid segments compositions and methods for the treatment of heart failure 07-29-2010
72. 20100184950 PROTEASE RESISTANT MUTANTS OF STROMAL CELL DERIVED FACTOR-1 IN THE REPAIR OF TISSUE DAMAGE 07-22-2010
73. 20100184848 TRANSDERMAL FORMULATIONS OF SYNTHETIC CANNABINOIDS AND NANO COLLOIDAL SILICA 07-22-2010
74. 20100184711 Alpha-GLYCOSYL THIOLS AND alpha-S-LINKED GLYCOLIPIDS 07-22-2010
75. 20100184081 GENETIC MARKERS FOR OBESITY - new genetic variants or polymorphisms at the perilipin locus including PLIN1: 6209T > 07-22-2010
76. 20100184051 METHODS OF GENERATING PLURIPOTENT CELLS FROM SOMATIC CELLS 07-22-2010
77. 20100184048 EPIDERMAL GROWTH FACTOR (EGF) EXPRESSION AND/OR POLYMORPHISMS THEREOF FOR PREDICTING THE RISK OF DEVELOPING CANCER 07-22-2010
78. 20100178304 METHOD FOR SILK FIBROIN GELATION USING SONICATION 07-15-2010
79. 20100178289 THERAPEUTIC USE OF IgG AS A NEUROPROTECTIVE AGENT 07-15-2010
80. 20100172976 METHODS AND COMPOSITIONS FOR INHIBITING THE FUNCTION OF POLYNUCLEOTIDE SEQUENCES 07-08-2010
81. 20100168016 DIAGNOSIS AND TREATMENT OF DISEASES CAUSED BY MISFOLDED PROTEINS 07-01-2010
82. 20100167418 STABILIZED LOW AFFINITY CONFORMATION OF INTEGRINS FOR DRUG DISCOVERY 07-01-2010
83. 20100166714 CARDIOVASCULAR STEM CELLS, METHODS FOR STEM CELL ISOLATION, AND USES THEREOF 07-01-2010
84. 20100160177 DIAGNOSTIC METHOD BASED ON LARGE SCALE IDENTIFICATION OF POST-TRANSLATIONAL MODIFICATION OF PROTEINS 06-24-2010
85. 20100158976 COLLAGEN/HYDROXYAPATITE COMPOSITE SCAFFOLD, AND PROCESS FOR THE PRODUCTION THEREOF 06-24-2010
86. 20100144776 USE OF SNPS FOR THE DIAGNOSIS OF A PAIN PROTECTIVE HAPLOTYPE IN THE GTP CYCLOHYDROLASE 1 GENE (GCH1) 06-10-2010
87. 20100144603 METHODS AND USES THEREOF OF PROSAPOSIN - methods for treating of tumor metastasis methods for preventing inhibiting 06-10-2010
88. 20100143313 HOMOGENEOUS DIFFERENTIATION OF HEPATOCYTE-LIKE CELLS FROM EMBRYONIC STEM CELLS 06-10-2010
89. 20100130574 NEURODEGENERATIVE DISEASES AND METHODS OF MODELING 05-27-2010
90. 20100129361 IMMUNOSUPPRESSION WITH ANTIBODY AGAINST ITM2A 05-27-2010
91. 20100120116 NANOPATTERNED BIOPOLYMER OPTICAL DEVICE AND METHOD OF MANUFACTURING THE SAME 05-13-2010
92. 20100112574 Method for the Simultaneous Determination of Blood Group and Platelet Antigen Genotypes 05-06-2010
93. 20100111894 METAP-2 INHIBITOR POLYMERSOMES FOR THERAPEUTIC ADMINISTRATION 05-06-2010
94. 20100105773 USE OF RESOLVINS AND DOCOSATRIENES AND ANALOGUES THEREOF FOR THE TREATMENT OF ANGIOGENESIS AND OCULAR NEOVASCULARIZATION 04-29-2010
95. 20100105136 CHIMERIC T-CELL RECEPTORS AND T-CELLS TARGETING EGFRVIII ON TUMORS 04-29-2010
96. 20100105071 METHODS FOR PREDICTING THE ONSET OF MENARCHE 04-29-2010
97. 20100105047 Method for the Simultaneous Determination of Blood Group and Platelet Antigen Genotypes 04-29-2010
98. 20100104579 TREX1 AS A MARKER FOR LUPUS ERYTHEMATOSUS 04-29-2010
99. 20100104556 EPITOPE-TAG FOR SURFACE-EXPRESSED PROTEINS AND USES THEREOF 04-29-2010
100. 20100096763 BIOPOLYMER OPTOFLUIDIC DEVICE AND METHOD OF MANUFACTURING THE SAME 04-22-2010
101. 20100087482 Method for Treating Gefitinib Resistant Cancer 04-08-2010
102. 20100081684 METHODS FOR TREATING INFLAMMATORY DISORDERS 04-01-2010
103. 20100070068 BIOPOLYMER SENSOR AND METHOD OF MANUFACTURING THE SAME 03-18-2010
104. 20100069251 METHODS FOR PRODUCING EMBRYONIC STEM CELLS FROM PARTHENOGENETIC EMBRYOS 03-18-2010
105. 20100068740 MICROFLUIDIC DEVICE WITH A CYLINDRICAL MICROCHANNEL AND A METHOD FOR FABRICATING SAME 03-18-2010
106. 20100065784 ELECTROACTIVE BIOPOLYMER OPTICAL AND ELECTRO-OPTICAL DEVICES AND METHOD OF MANUFACTURING THE SAME 03-18-2010
107. 20100063404 BIOPOLYMER OPTICAL WAVEGUIDE AND METHOD OF MANUFACTURING THE SAME 03-11-2010
108. 20100062534 INDUCIBLE LENTIVIRAL VECTORS FOR REPROGRAMMING SOMATIC CELLS 03-11-2010
109. 20100061992 THERAPEUTIC USES OF TIM-3 MODULATORS - The invention provides novel methods of treating neurological disorders, including neurodegenerative disorders 03-11-2010
110. 20100056445 ADIPONECTIN FOR THE TREATMENT AND DIAGNOSIS OF ALBUMINURIA 03-04-2010
111. 20100055438 CONCENTRATED AQUEOUS SILK FIBROIN SOLUTION AND USE THEREOF 03-04-2010
112. 20100048705 METHODS OF TREATING AND PREVENTING NEOVASCULARIZATION WITH OMEGA-3 POLYUNSATURATED FATTY ACIDS 02-25-2010
113. 20100048479 ADRENAL GRK2 ACTIVITY AS A THERAPEUTIC TARGET FOR HEART FAILURE 02-25-2010
114. 20100047798 ADENOSINE A1 AND A3 RECEPTOR GENE SEQUENCE VARIATIONS FOR PREDICTING DISEASE OUTCOME AND TREATMENT OUTCOME 02-25-2010
115. 20100046902 BIOPOLYMER PHOTONIC CRYSTALS AND METHOD OF MANUFACTURING THE SAME 02-25-2010
116. 20100040584 METHODS FOR PROMOTING NEOVASCULARIZATION 02-18-2010
117. 20100035843 METHODS FOR ATTENUATING ALLERGEN-INDUCED AIRWAY HYPERREACTIVITY USING CD1D DEPENDENT ANTAGONISTS 02-11-2010
118. 20100035312 IMMOBILIZED INTERFACIAL ENZYMES OF IMPROVED AND STABILIZED ACTIVITY 02-11-2010
119. 20100035287 Secreted Luciferase Fluorescent Protein Conjugate Nucleic Acid Construct and Uses Thereof 02-11-2010
120. 20100035257 METHODS TO DETERMINE THE RESPONSIVENESS TO CISPLATIN TREATMENT 02-11-2010
121. 20100035225 ADAPTIVE SPACED TEACHING METHOD AND SYSTEM 02-11-2010
122. 20100029747 METHODS AND COMPOSITIONS FOR INHIBITING THE FUNCTION OF POLYNUCLEOTIDE SEQUENCES 02-04-2010
123. 20100029568 TIGHTER-BINDING C-PEPTIDE INHIBITORS OF HIV-1 ENTRY 02-04-2010
124. 20100029549 SITU SELF-SETTING MINERAL-POLYMER HYBRID MATERIALS, COMPOSITION AND USE THEREOF 02-04-2010
125. 20100028931 Neurodegenerative diseases and methods of modeling 02-04-2010
126. 20100028451 SILK MICROSPHERES FOR ENCAPSULATION AND CONTROLLED RELEASE 02-04-2010
127. 20100028434 Temperature controlled and pH dependent self gelling biopolymeric aqueous solution 02-04-2010
128. 20100021915 HIGH THROUGHPUT DNA SEQUENCING METHOD AND APPARATUS 01-28-2010
129. 20100021545 INJECTABLE IN SITU SELF-FORMING MINERAL-POLYMER HYBRID COMPOSITION AND USES THEREOF 01-28-2010
130. 20100016170 HIGH THROUGHPUT METHOD FOR DISCOVERY OF GENE CLUSTERS 01-21-2010
131. 20100008937 TARGETED DELIVERY TO LEUKOCYTES USING NON-PROTEIN CARRIERS 01-14-2010
132. 20100003269 METHODS AND USES OF CAULIFLOWER AND COLLARD FOR RECOMBINANT PROTEIN PRODUCTION 01-07-2010
133. 20090325867 RECEPTOR-SPECIFIC TUMOUR NECROSIS FACTOR-RELATED APOPTOSIS-INDUCING LIGAND (TRAIL) VARIANTS 12-31-2009
134. 20090318391 ANTI-CANCER THERAPY COMPRISING AN H2-BLOCKER, AT LEAST ONE ANTIINFLAMMATORY AGENT AND A CYTOTOXIC AGENT 12-24-2009
135. 20090306776 METHODS AND PROCEDURES FOR LIGAMENT REPAIR 12-10-2009
136. 20090305225 Inhibition of Creatine Uptake to Promote Weight Loss 12-10-2009
137. 20090304680 DIAGNOSIS AND TREATMENT OF KAWASAKI DISEASE 12-10-2009
138. 20090304642 METHODS OF SPECIFYING MESODERMAL, ENDODERMAL AND MESOENDODERMAL CELL FATES 12-10-2009
139. 20090298913 SMALL INTERFERING OLIGONUCLEOTIDES COMPRISING ARABINOSE MODIFIED NUCLEOTIDES 12-03-2009
140. 20090286855 INTERLEUKIN-18 MUTANTS, THEIR PRODUCTION AND USE 11-19-2009
141. 20090285860 Cancer immunotherapy - Method of stimulating an immune response include administering to a subject a composition including dendritic cells incubated 11-19-2009
142. 20090285786 METHOD TO MODULATE HEMATOPOIETIC STEM CELL GROWTH 11-19-2009
143. 20090280130 METHOD FOR THE TREATMENT OF ANTHRAX TOXICITY 11-12-2009
144. 20090275635 SCREENING METHOD - method of modulating Wnt signalling comprising modulating Trabid activity 11-05-2009
145. 20090274772 DISINFECTANT COMPOSITIONS AND METHODS OF USE THEREOF 11-05-2009
146. 20090269775 PROGNOSTIC MARKERS FOR CLASSIFYING COLORECTAL CARCINOMA ON THE BASIS OF EXPRESSION PROFILES OF BIOLOGICAL SAMPLES 10-29-2009
147. 20090263464 BLADDER RECONSTRUCTION - The invention is directed to methods and devices for the reconstruction repair augmentation or replacement of laminarily 10-22-2009
148. 20090259044 COMPOSITIONS AND METHODS FOR MODULATING SIRTUIN ACTIVITY 10-15-2009
149. 20090257953 NOVEL FLUORINE-18 LABELED RHODAMINE DERIVATIVES FOR MYOCARDIAL PERFUSION IMAGING WITH POSITRON EMISSION TOMOGRAPHY 10-15-2009
150. 20090254104 METHODS AND COLLAGEN PRODUCTS FOR TISSUE REPAIR 10-08-2009
151. 20090232963 DIAZONIUM SALT MODIFICATION OF SILK POLYMER 09-17-2009
152. 20090232730 METHOD OF PRODUCING IMMUNOLIPOSOMES AND COMPOSITIONS THEREOF 09-17-2009
153. 20090231340 METHOD AND SYSTEM FOR GRAPHICALLY DISPLAYING DATA 09-17-2009
154. 20090222282 Method for Personalized Diet Design - methods of developing dietary guidelines particularly associated with dietary consumption of fatty acids 09-03-2009
155. 20090221533 METHOD OF TREATING FATTY LIVER DISEASE - method for treating a fatty liver disease or disorder in a patient in need thereof 09-03-2009
156. 20090220994 METHODS FOR DIAGNOSIS OF CHRONIC PROSTATITIS/CHRONIC PELVIC PAIN SYNDROME 09-03-2009
157. 20090220932 DEVICE AND METHOD FOR COMBINED MICROFLUIDIC-MICROMAGNETIC SEPARATION OF MATERIAL IN CONTINUOUS FLOW 09-03-2009
158. 20090220606 TREATMENT AND PREVENTION OF ABNORMAL CELLULAR PROLIFERATION 09-03-2009
159. 20090220517 METHOD FOR PRODUCING EPITOMERS AND THEIR USES ON CARRIER MICROORGANISMS 09-03-2009
160. 20090215861 Antisense oligonucleotides for treating allergy and neoplastic cell proliferation 08-27-2009
161. 20090215723 Organic silicic acids complex for therapeutic and cosmetic applications 08-27-2009
162. 20090215175 MODULATION OF THE POLIOVIRUS RECEPTOR FUNCTION 08-27-2009
163. 20090203590 METHOD FOR THE INHIBITION OF ANGIOGENESIS 08-13-2009
164. 20090203014 METHOD FOR DIAGNOSING AUTISM SPECTRUM DISORDER 08-13-2009
165. 20090202614 METHODS FOR STEPWISE DEPOSITION OF SILK FIBROIN COATINGS 08-13-2009
166. 20090202497 USE OF GLP-1, GLP-1 DERIVATIVES OR GLP-1 FRAGMENTS FOR SKIN REGENERATION, STIMULATION OF HAIR GROWTH, OR TREATMENT OF DIABETES 08-13-2009
167. 20090202493 MIR-150 FOR THE TREATMENT OF BLOOD DISORDERS 08-13-2009
168. 20090202430 COMPOSITION FOR CYTOCOMPATIBLE, INJECTABLE, SELF-GELLING POLYSACCHARIDE SOLUTIONS FOR ENCAPSULATING AND DELIVERING LIVE CELLS OR BIOLOGICALLY ACTIVE FACTORS 08-13-2009
169. 20090197511 DOSING DEVICE - for a particulate material blasting apparatus comprising a dosing chamber having a base 08-06-2009
170. 20090181369 Methods for the Treatment of Disease - methods to determine the likelihood of therapeutic effectiveness of a farnesyl transferase inhibitor 07-16-2009
171. 20090178146 Regulators of NFAT - Disclosed are methods of identifying an agent that modulates an NFAT regulator protein 07-09-2009
172. 20090176874 TNP-470 POLYMER CONJUGATES AND USE THEREOF 07-09-2009
173. 20090176226 METHOD FOR DIAGNOSING AUTISM SPECTRUM DISORDER 07-09-2009
174. 20090176218 Method for the Diagnosis and Prognosis of Cancer 07-09-2009
175. 20090170165 METHOD FOR RECOMBINANT PRODUCTION IN CHO CELLS 07-02-2009
176. 20090162515 Method of Preparation of Adapted Foods - method of preparing adapted foods where the composition allows the facilitation of the acts of eating or 06-25-2009
177. 20090156496 METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING PERIPHERAL NERVE DAMAGE 06-18-2009
178. 20090156491 METHODS OF INHIBITING ANGIOGENESIS WITH FRAGMENTS AND HOMOLOGS OF TROPONIN SUBUNIT I 06-18-2009
179. 20090149421 GEL FORMATION OF POLYELECTROLYTE AQUEOUS SOLUTIONS BY THERMALLY INDUCED CHANGES IN IONIZATION STATE 06-11-2009
180. 20090148494 EGFR INHIBITORS PROMOTE AXON REGENERATION 06-11-2009
181. 20090136489 METHODS FOR THE TREATMENT, DIAGNOSIS, AND PROGNOSIS OF CANCER 05-28-2009
182. 20090123439 DIAGNOSTIC AND PROGNOSIS METHODS FOR CANCER STEM CELLS 05-14-2009
183. 20090120147 ENHANCED FERTILIZER AND METHOD FOR PRODUCING SAME 05-14-2009
184. 20090110687 COMPOSITIONS AND METHODS RELATED TO TIM 3, A TH1-SPECIFIC CELL SURFACE MOLECULE 04-30-2009
185. 20090104175 USE OF CASPASES FOR THE PREPARATION OF MEDICAMENTS 04-23-2009
186. 20090101809 MASS SPECTROMETRY-BASED QUANTITATIVE ASSAY FOR DETERMINING ABUNDANCE OF MOLECULAR SPECIES IN A COMPOSITION 04-23-2009
187. 20090092652 Method for the inhibition of angiogenesis or cancer using protective antigen related molecules 04-09-2009
188. 20090075383 COMPOSITION AND METHOD FOR EFFICIENT DELIVERY OF NUCLEIC ACIDS TO CELLS USING CHITOSAN 03-19-2009
189. 20090074710 METHOD OF TREATMENT USING A CYTOKINE ABLE TO BIND IL-18BP TO INHIBIT THE ACTIVITY OF A SECOND CYTOKINE 03-19-2009
190. 20090069559 Compositions and methods for modulating sirtuin activity 03-12-2009
191. 20090062771 BALLOON-TIPPED NASOGASTRIC FEEDING TUBE - feeding tube for insertion into a digestive system of a subject includes a tube having a distal end and a 03-05-2009
192. 20090061019 DISINFECTANT COMPOSITIONS AND METHODS OF USE THEREOF 03-05-2009
193. 20090047338 Method to Treat Flavivirus Infection with siRNA 02-19-2009
194. 20090030525 METHOD FOR RESTORING A DAMAGED OR DEGENERATED INTERVERTEBRAL DISC 01-29-2009
195. 20090029938 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS FOR TREATING DISEASE INCLUDING INFLAMMATORY CONDITIONS 01-29-2009
196. 20090029920 Methods and Compositions for Treating Ocular Disorders 01-29-2009
197. 20090023977 Method of Treatment to Improve Concentration and/or Memory in a Subject in Need Thereof 01-22-2009
198. 20090022862 Method to limit acrylamide in heated foods 01-22-2009
199. 20090022783 siRNA MICROBICIDES FOR PREVENTING AND TREATING DISEASES 01-22-2009
200. 20090010887 Method and composition for enhancing anti-angiogenic therapy 01-08-2009
201. 20090004163 METHOD OF ENHANCING PROLIFERATION AND/OR HEMATOPOIETIC DIFFERENTIATION OF STEM CELLS 01-01-2009
202. 20080318908 USE OF GABA AND GABAB AGONISTS - methods of stimulating tissue growth including islet cell growth 12-25-2008
203. 20080311130 Integrin Alpha L I Domain Mutants with Increased Binding Affinity 12-18-2008
204. 20080306002 Combination Therapy for Preventing Angiogenesis 12-11-2008
205. 20080300683 PROSTHETIC DEVICE AND METHOD OF MANUFACTURING THE SAME 12-04-2008
206. 20080293919 Fibrous Protein Fusions and Use Thereof in the Formation of Advanced Organic/Inorganic Composite Materials 11-27-2008
207. 20080293661 METHOD FOR TREATING CHRONIC LYMPHOID LEUKEMIA 11-27-2008
208. 20080280829 METHODS OF TREATMENT AND PREVENTION OF METABOLIC BONE DISEASES AND DISORDERS 11-13-2008
209. 20080280360 Method for Producing Biomaterial Scaffolds 11-13-2008
210. 20080279846 METHODS OF TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES AND DISORDERS 11-13-2008
211. 20080275728 Method for Personalized Diet Design for Females of Asian Origin 11-06-2008
212. 20080275119 Treatment and Prevention of Liver Disease Associated with Parenteral Nutrition (PN) 11-06-2008
213. 20080268463 Methods for Prognosis and Diagnosis of Chronic Prostatitis/Pelvic Pain Syndrome and Interstitial Cystitis 10-30-2008
214. 20080268432 Method for detection of staphylococcus epidermidis 10-30-2008
215. 20080267908 Il-32 Modulators - methods of screening for modulators of interleukin 32 , to modulators of IL-32 and to their use 10-30-2008
216. 20080261867 Soluble inhibitors of vascular endothelial growth factor and use thereof 10-23-2008
217. 20080261205 Method for the Simultaneous Determination of Blood Group and Platelet Antigen Genotypes 10-23-2008
218. 20080248030 Method of Treating Angiogenic Diseases - methods for treating cancer comprising administering an anti-VEGF monoclonal antibody and a N-methacrylamide 10-09-2008
219. 20080234385 Method For Inhibiting Tnf-Alpha - The present invention encompasses methods for inhibiting TNF-alpha expression with N-substituted dopamine derivatives 09-25-2008
220. 20080234264 Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments 09-25-2008
221. 20080227733 Method for Treating and Preventing Ischemia-Reperfusion Injury Using Rna Interfering Agent 09-18-2008
222. 20080220424 Method for Predicting Responsiveness to Drugs 09-11-2008
223. 20080213369 SYNTHETIC PLATELETS - synthetic platelet substitute that interacts with platelets and the endothelium comprising: a carrier molecule comprising lipidic 09-04-2008
224. 20080213252 METHODS OF TREATING ITCH - The invention provides methods for preventing and/or treating itch in a subject in need thereof by administration of a 09-04-2008
225. 20080207615 Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments 08-28-2008